Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 156 results found. Search for [ Pfizer vaccine candidate ]

Results 40 to 60 of 156
BusinessToday.In
November 15, 2020
As per Anthony Fauchi, the Pfizer's vaccine distribution process in the US will start in December. This, he said, will also help reduce the daily spike in coronavirus cases, which reached 1.9 lakh this week


BusinessToday.In
November 13, 2020
Pfizer and BioNTech recently announced that their vaccine candidate BNT162b2 has shown over 90 per cent efficacy in preventing coronavirus, as per data from Phase III clinical trials


BusinessToday.In
November 13, 2020
Serum Institute has tied up with five developers that have made 40 million doses of the coronavirus vaccine in the past two months. They are aiming to start manufacturing of Novavax's candidate soon


BusinessToday.In
November 12, 2020
US-based Moderna Inc has claimed that it has sufficient data for a first interim analysis of the advanced-phase trial of its COVID-19 vaccine candidate, which should help ascertain the inoculation's efficacy


BusinessToday.In
November 12, 2020
Pfizer COVID-19 vaccine would need to be stored at -70 degree Celsius, which experts believe, would be a daunting challenge even for the best medical centres


Reuters
November 11, 2020
Scientists, public health officials and investors welcomed the first successful interim data from a large-scale clinical test as a watershed moment that could help turn the tide of the pandemic if the full trial results pan out


BusinessToday.In
November 11, 2020
COVAXIN's phase-3 trial at AMU is aimed at checking the safety and effectiveness of the COVID-19 vaccine, jointly developed by the Hyderabad-headquartered Bharat Biotech, National Institute of Virology (NIV) and Indian Council of Medical Research (ICMR)


PTI
November 11, 2020
Pfizer Inc and BioNTech SE have said that their vaccine candidate has been found to be more than 90 per cent effective in preventing COVID-19


BusinessToday.In
November 11, 2020
More than 43,500 volunteers across 6 countries have participated in the phase-3 trials run jointly by the New York-headquartered pharma giant and the German pharma behemoth BioNTech


BusinessToday.In
November 11, 2020
Share of Pfizer gained 3.76% to Rs 5238 against previous close of Rs 5048 on BSE


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 11, 2020
Coronavirus vaccine: India will focus on these two vaccines as they are being tested on the Indian population and hence has a major advantage over other potential candidates


BusinessToday.In
November 11, 2020
Stocks to watch today on November 11: Wipro, NMDC, Pfizer, Infosys, YES Bank, ONGC among others are the top stocks to watch out for in Wednesday's trading session


Chitranjan Kumar
November 10, 2020
COVID-19 vaccine update: Croda's deal with Pfizer runs for five years and awards Croda an initial supply contract for four component excipients used in the production of the vaccine candidate for the first three years of the contract


Rupa Burman Roy
November 10, 2020
Further, domestic investors are also hoping for more stimulus measures announcements from the government in the near future, required to boost the economy


Aseem Thapliyal
November 10, 2020
Among hotel stocks, Indian Hotels Co. Ltd rose 14%, EIH 7.54%, TajGVK Hotels and Resorts 3.18%, Chalet Hotels 7.84%, Mahindra Holidays 4.6%, Wonderla Holidays 12.75% and Advani Hotels & Resorts 12%


PTI
November 10, 2020
They reported the design of a 'heat-tolerant' COVID-19 vaccine candidate and a rapid method to identify specific regions on the HIV envelopeprotein that are targeted by antibodies, which can help design effective vaccines


Anwesha Madhukalya
November 10, 2020
Pfizer and BioNTech coronavirus vaccine: Logistical challenges such as ultra-low temperature storage could hamper the distribution plans not only in developing nations like India but also in advanced countries like the US


Rajeev Dubey
New Delhi, November 10, 2020
In a major breakthrough in COVID-19 vaccine work, American pharmaceutical giant Pfizer and German firm BioNTech claimed that their vaccine candidate has been found to be 90% effective. The vaccine firms are the first drugmakers to show successful data from a large-scale clinical trial of coronavirus vaccine. The shots made by Pfizer and its German partner BioNTech are among 10 possible vaccine candidates in late-stage testing around the world. How Pfizer vaccine will act as a game changer for the US market, Rajeev Dubey, Editor, Business Today explains.Also Read: Sensex crosses 43,000 for first time, Nifty nears 12,600 on COVID-19 vaccine hopes


Shailendra Shukla
New Delhi, November 10, 2020
Wipro employees to get single digit pay hike effective December 1 IT major Wipro will offer a single digit salary hike as well as promotions to its high quality performers effective December 1. Pay hike and promotions will be rewarded to employees in bands up to B3 account, who constitute about 80 per cent of the company's total workforce. The company is yet to take a decision on offering salary increments to senior employees above B3 band. Tanishq withdraws another Diwali ad after Twitte...


PAGES 3 OF 8  12345